Hopp til hovedinnhold Gå til bunntekst
  • Science
  • E-learnings
  • Webinars
  • Podcasts
  • Science
  • E-learnings
  • Webinars
  • Podcasts
  • Science
  • E-learnings
  • Webinars
  • Podcasts

RRMM

Framingham issue 2 2022

Download issue 2
Share this article with your colleagues

MAT-DK-2200082 (ver.2) 03 2022

Also interesting...

NK Cells, RRMM

Review: NK cell therapy in relapsed refractory multiple myeloma

RRMM

Framingham Issue 2 2023

RRMM

Framingham Issue 1 2023

MRD, NDMM, RRMM

MRD as primary endpoint

MRD, NDMM, RRMM

Minimal Residual Disease (MRD) – Cost vs Benefit
MyelomaPlatform is supported by an educational grant of Sanofi

Interested in receiving updates on Medical Educational initiatives?

Yes, I am interested
© Copyright 2023, Myeloma Platform
MAT-NL-2200258 – 1.0 – 03/2022
Terms and conditionsCookiesPrivacyContact

Login

RegistrerenWachtwoord vergeten?